The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports
Philadelphia, PA USA, London UK, August 13, 2008
Read on...
Thomson Reuters Adds New Resources To Citation Impact Center
Philadelphia, PA USA, London UK, August 13, 2008
Read on...
Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook
London, UK, July 24, 2008
Read on...
Thomson Reuters Adds Citation Mapping Tool To ISI Web of Knowledge
Philadelphia, PA, London, UK, July 23, 2008
Read on...
|
Operation optimization
Pharmaceutical Executive Europe, February 2007
In response to new requirements, life sciences companies around the world are rethinking their regulatory activities, creating new opportunities for operational excellence. Jim Nichols explores some of the new concepts that are making a difference.
View Article
Tackling the TB threat
Pharmaceutical Marketing Europe, November 2006
The tuberculosis (TB) market is historically one of perceived low value, limited growth and reduced opportunities for the pharma industry. However, the continued health, social and economic problems that the disease poses, and the emergence of multidrug-resistant forms and rising infection rates in the developed world, have renewed interest in the development of effective prophylactic and therapeutic options.
View Article
|
|
|
